More about Apollo Hospitals Enterprise Limited
Fundamentals for Apollo Hospitals Enterprise Limited
Regulatory Filings for Apollo Hospitals Enterprise Limited
Why Oman Is Now India's Most Strategic Trade Partner
Infrastructure Bet Fuels Cement Surge
Apollo FY26: When Healthcare Becomes a Flywheel
NITI Blueprint Could Turn Brain Drain Into $135Bn Engine
Fundamentals for Apollo Hospitals Enterprise Limited
Business Operations:
Sector: HealthcareIndustry: Medical Care Facilities
Apollo Hospitals Enterprise Limited, together with its subsidiaries, engages in the provision of healthcare services in India and internationally. It operates through Healthcare Services, Retail Health & Diagnostics, Digital Health & Pharmacy Distribution, and Others segments. The company's healthcare facilities comprise primary, secondary, and tertiary care, as well as specialty facilities. It offers services in cardiac sciences, orthopedics, oncology, neurosciences, emergency, robotic surgery, and transplants; and cardiology, neurology, gastroenterology, dermatology, ophthalmology, pediatric, endocrinology, gynecology, urology, nephrology, pulmonology, rheumatology, neurosurgery, radiology, plastic-surgery, neonatology, vascular-surgery, psychiatry, dentistry, ear, nose, and throat care, as well as genomic medicines. The company also provides other services, such as project consultancy, health insurance, medical colleges, medvarsity for e-learning, and research services. In addition, it operates pharmacies, primary care clinics, birthing centers, specialized birthing centers, dialysis centers, cradle and fertility centers, diabetes management centers, single specialty clinics, primary health centers and diagnostic chains, dental clinics, and daycare and home healthcare centers. Further, the company engages in the business of bio-banking of tissues. It serves through national retail healthcare centers and genomics institutes, as well as Apollo 24/7, a digital health mobile platform; and www.apollopharmacy.in, an online pharmacy. The company was incorporated in 1979 and is based in Chennai, India.
Revenue projections:
Investors may be wary of Apollo Hospitals Enterprise Limited as its revenues are expected to fall below the prior year's levels. A revenue decrease often leads to concerns about profitability, as it is likely to affect the company's bottom line, prompting investors to take a more cautious approach.
Financial Ratios:
| currentRatio | 1.065000 |
|---|---|
| forwardPE | 37.840576 |
| debtToEquity | 85.146000 |
| earningsGrowth | 0.356000 |
| revenueGrowth | 0.181000 |
| grossMargins | 0.362790 |
| operatingMargins | 0.119080 |
| trailingEps | 135.410000 |
| forwardEps | 213.778460 |
Apollo Hospitals Enterprise Limited's current ratio being 1.065 suggests that it has more than enough liquidity to cover short-term debt obligations. The company's cash reserves and current assets are sufficient to meet immediate liabilities, signaling solid financial health and minimal risk.
Apollo Hospitals Enterprise Limited's high debt-to-equity ratio reveals that the company is heavily reliant on debt for financing. This high level of leverage increases the risk of financial strain if profits decline or interest rates rise.
APOLLOHOSP's positive earnings and revenue growth suggest that the company is expected to expand its business. This reflects a healthy financial outlook, as APOLLOHOSP's increasing profits and sales signal further growth in the near future.
APOLLOHOSP's forward EPS surpassing its trailing EPS signals that the company is anticipated to be more profitable this year than last. This growth expectation highlights APOLLOHOSP's potential for increased earnings and a stronger financial performance in the upcoming year.
Price projections:
Over time, price projections for APOLLOHOSP have gradually increased, reflecting rising confidence in the company's future performance. This upward trend suggests analysts expect APOLLOHOSP to continue on a positive growth trajectory.
Insider Transactions:
2 buy transactions of APOLLOHOSP stock were completed, with market price at 6616.0.There were no buy transactions recorded during the period under consideration.APOLLOHOSP's current price levels have seen more sells, possibly signaling bearish sentiment. If this trend remains unchanged, the stock could experience further declines as more investors opt to sell rather than hold their positions.
Recommendation changes over time:
Analysts' buy bias for APOLLOHOSP signals that the stock is considered a favorable investment. This outlook might prompt investors to allocate funds to APOLLOHOSP, seeing it as a solid and profitable choice to park their money and potentially benefit from the company's long-term growth.
If you have enjoyed reading, spread the word:
Good prospects:
Companies with the best and the worst fundamentals.
Latest Regulatory Filings for NSE500
Companies with the best and the worst technicals.
RAINMUMBAI Turns Rain Into a Financial Asset
India’s IT Sector Faces a Historic Breaking Point
How Independent Directors Failed Rs 2,500 Crore in Value